Batch processing operations are ideal for large scale manufacturing of products that are assembled and modified in a series of stages or steps. When connected to a batch management software system, ...

Reframing pharmaceutical production around process stability, real-time quality assurance, and regulatory alignment in the ...

Learn how a move from time-based filling to precision flow meters improved batch accuracy by 98% and increased daily throughput by 14%. Understand how flow measurement improvements create ripple ...

In drug-making operations, use of hot melt extrusion, a continuous processing technology, tops batch processing by requiring less offline testing and fewer operator interventions, which can yield ...

A primary cost ingredient in manufacturing pharmaceutical products is the time and effort required to build the master batch record (MBR) after the processing steps have been completed. Gathering ...

In an industry where product quality increasingly determines competitive advantage, the ability to see what you're processing ...

Continuous manufacturing makes monoclonal antibody production faster, cheaper, and greener, say researchers, who predict that industry adoption of the approach will accelerate in response to ...

Biologics developers are caught in a paradox: demand for therapies is climbing, but the industry faces constant pressure to cut costs and move faster. For upstream process scientists, the challenge is ...

New recipe and materials management, batch execution, and compliance capabilities in Oracle Fusion Cloud SCM help customers improve control, enhance quality, and lower risk "Process manufacturers in ...

SHANGHAI, Aug. 30, 2024 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), today announced that it has ...

Explore how parenteral manufacturing solutions are evolving for specific drug formulations and meeting the demands of advanced therapies.

Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...